title: Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomes.
abstract: Clinical trials in nephrology have focused on achieving targets, supplementing deficiencies, and correcting excesses in order to improve patient outcomes. The majority of interventions have failed to demonstrate benefit and some have caused harm. It may be that therapies aiming to 'normalize' parameters may actually disturb evolutionary adaptation, thus causing harm. By refocusing on the physiology of disease, and complexity of adaptation, we may design better trials. We review successful and unsuccessful trials in nephrology and other disciplines and suggest a set of principles by which to design future clinical trials:(1) acknowledge heterogeneity of chronic kidney disease populations and appropriately characterize populations for studies; (2) develop better validated biomarkers (through proteomics, genomics, and metabolomics) to identify responders and nonresponders to interventions; (3) design interventions that mimic physiological processes without collateral detrimental effects; (4) reconsider the status of the randomized-controlled trial as the only 'gold standard' and perform large-scale pragmatic trials comparing current care with the intervention(s) of interest, and (5) broaden nephrology research culture so that the majority of patients are enrolled into observational cohorts and intervention studies, which foster greater knowledge acquisition and dissemination. Improved understanding of pathophysiological mechanisms, in conjunction with more innovative but stringent clinical trial design, will ultimately lead to improved patient outcomes.
authors.affiliation: Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada. alevin@providencehealth.bc.ca
authors.forename: Adeera
authors.initials: A
authors.lastname: Levin
authors.forename: William
authors.initials: W
authors.lastname: Lancashire
authors.forename: Robert G
authors.initials: RG
authors.lastname: Fassett
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D004059:Diffusion of Innovation; D018450:Disease Progression; D006302:Health Services Research / Q000379:methods* / Q000592:standards; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D009398:Nephrology / Q000592:standards; D063868:Patient Outcome Assessment; D018579:Patient Selection; D019984:Quality Indicators, Health Care; D012107:Research Design / Q000592:standards; D057170:Translational Research, Biomedical; D016896:Treatment Outcome